Overview

Bioavailability Study of Duloxetine Delayed-Release Capsules 60 mg Under Fasting Condition

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
This study were to compare the relative bioavailability of Duloxetine HCl delayed release capsule 60 mg with that of 'CYMBALTA®' delayed release capsule 60 mg (Duloxetine HCl delayed release capsule 60 mg) in healthy, adult, human subjects under fasting conditions and to monitor safety of subjects
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Duloxetine Hydrochloride